Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer

Filippo Montemurro; Caterina Marchiò; Anna Sapino

doi:10.1001/jamaoncol.2019.6706

Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer

Filippo Montemurro, Caterina Marchiò, Anna Sapino

Istituto Oncologico Candiolo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	584-585
Number of pages	2
Journal	JAMA oncology
Volume	6
Issue number	4
DOIs	https://doi.org/10.1001/jamaoncol.2019.6706
Publication status	Published - Apr 1 2020

Keywords

Breast Neoplasms/drug therapy
Chemotherapy, Adjuvant
Humans
Neoplasm Recurrence, Local
Receptors, Estrogen

Access to Document

10.1001/jamaoncol.2019.6706

Cite this

@article{e13ea1daf2e140ba9a481f290aeaf503,

title = "Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer",

keywords = "Breast Neoplasms/drug therapy, Chemotherapy, Adjuvant, Humans, Neoplasm Recurrence, Local, Receptors, Estrogen",

author = "Filippo Montemurro and Caterina Marchi{\`o} and Anna Sapino",

year = "2020",

month = apr,

day = "1",

doi = "10.1001/jamaoncol.2019.6706",

language = "English",

volume = "6",

pages = "584--585",

journal = "JAMA oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "4",

}

TY - JOUR

T1 - Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer

AU - Montemurro, Filippo

AU - Marchiò, Caterina

AU - Sapino, Anna

PY - 2020/4/1

Y1 - 2020/4/1

KW - Breast Neoplasms/drug therapy

KW - Chemotherapy, Adjuvant

KW - Humans

KW - Neoplasm Recurrence, Local

KW - Receptors, Estrogen

U2 - 10.1001/jamaoncol.2019.6706

DO - 10.1001/jamaoncol.2019.6706

M3 - Article

C2 - 32053151

VL - 6

SP - 584

EP - 585

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

IS - 4

ER -